News
Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Science Minister Lord Vallance opens Digital and Automation Testbeds that will improve advanced therapies manufacturingRegulatory Round-up - May 2025The digital revolution in cell and gene therapy: Insights from Advanced Therapies Integrates NorthCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and JapanChallenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionRegulatory Round-up - April 2025INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessRegulatory Round-up - March 2025Regulatory Round-up - February 2025Network established to identify opportunities for regulation to support innovation within advanced therapiesRegulatory Round-up - January 202570% increase in Phase I advanced therapy clinical trials in the UK in 2024
